The Dystonia Gene Panel by NGS / EDTA Blood is an advanced genetic test designed to detect mutations linked to various forms of hereditary and early-onset dystonia. Using high-resolution Next-Generation Sequencing, it helps identify the underlying genetic cause of involuntary muscle contractions and movement disorders. Metropolis Healthcare performs this test with cutting-edge genomic technology to ensure accurate and clinically meaningful results. It is particularly valuable for individuals with unexplained dystonia or a family history of movement disorders.
Price:
Rs. 20,000.00
Sample Type: EDTA Blood
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the Dystonia Gene Panel by NGS include?
This panel at Metropolis Healthcare analyzes multiple genes associated with hereditary and early-onset dystonia.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses highly sensitive Next-Generation Sequencing to detect gene mutations from an EDTA blood sample.
Who should take this test?
Individuals experiencing unexplained dystonia, early-onset movement symptoms, or those with a family history may benefit from this test at Metropolis Healthcare.
Why is genetic testing important for dystonia?
Metropolis Healthcare offers this test to identify genetic causes that help guide treatment, prognosis, and long-term management.
What sample is required for the test?
An EDTA blood sample is collected and processed at Metropolis Healthcare for genetic sequencing.
Do I need any special preparation before the test?
No preparation is required; Metropolis Healthcare handles all DNA extraction and sequencing procedures.
How long do results take?
Metropolis Healthcare generally provides results within a clinically appropriate timeframe for NGS-based panels.
Can this test support treatment planning or counseling?
Yes, doctors use Metropolis Healthcare’s results to guide therapy options, neurologic evaluation, and genetic counseling.